Yunpeng Gu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Promising Digital Therapeutics for Nonalcoholic Steatohepatitis: More Efforts Are Needed.
Journal: The American journal of gastroenterology
Published: August 30, 2023
Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials.
Journal: Expert review of gastroenterology & hepatology
Published: January 23, 2023
Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials.
Journal: Frontiers in pharmacology
Published: November 19, 2022
Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease.
Journal: Clinical and translational gastroenterology
Published: October 18, 2022
Barriers and enabling factors in weight management of patients with nonalcoholic fatty liver disease: A qualitative study using the COM-B model of behaviour.
Journal: Health expectations : an international journal of public participation in health care and health policy
Published: June 10, 2022
Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Journal: Clinics and research in hepatology and gastroenterology
Published: January 10, 2022
Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies.
Journal: Journal of affective disorders
Published: July 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026